TAMPA, Fla. and LONDON, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology ...

Antibody drug conjugates have fast become a big piece of AstraZeneca’s revenue growth. The drugmaker is taking steps to ensure it has the production capacity to meet market demand for these cancer ...

The "ADC Contract Manufacturing Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Stage of Development, Process Component, Target Indication, Antibody Generation, Antibody ...

14 May 2018, Wales: ADC Biotechnology (ADC Bio), together with Maven Capital Partners and Bioscience Managers, is to host a webinar through ADC Review entitled ‘Investing for the future: unlocking ...

Akari Therapeutics, Plc, an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads, ...

The antibody-drug conjugate (ADC) manufacturing landscape offers the potential to leverage significant opportunities for cancer treatment, but faces complex challenges. Nevertheless, the ADC market ...

While the race is on to develop antibody-drug conjugate (ADC) cancer treatments, so too is the competition to manufacture them. Hoping to gain an edge in the rapidly growing market are MilliporeSigma ...

Analog integrated circuits (ICs) are used to control and regulate conditions such as temperature, speed, sound, and electrical current. In analog ICs, voltage and current vary continuously at ...

The tradeoff between integrated and standalone ADCs regarding performance, specification, complexity, robustness, and cost. How to evaluate which analog technology to use to meet your application ...